Autor: "Lau JSM" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.
Autorzy:: Gill H; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Yim R; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Pang HH; School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
Lee P; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Chan TSY; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Hwang YY; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Leung GMK; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Ip HW; Department of Pathology, Queen Mary Hospital, Hong Kong SAR, China.
Leung RYY; Department of Pathology, Queen Mary Hospital, Hong Kong SAR, China.
Yip SF; Department of Medicine, Tuen Mun Hospital, Hong Kong SAR, China.
Kho B; Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
Lee HKK; Department of Medicine, Princess Margaret Hospital, Hong Kong SAR, China.
Mak V; Department of Medicine, Princess Margaret Hospital, Hong Kong SAR, China.
Chan CC; Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China.
Lau JSM; Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China.
Lau CK; Department of Medicine, Tseung Kwan O Hospital, Hong Kong SAR, China.
Lin SY; Department of Medicine, United Christian Hospital, Hong Kong SAR, China.
Wong RSM; Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China.
Li W; Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong SAR, China.
Ma ESK; Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong SAR, China.
Li J; Department of Infectious Diseases and Public Health, The City University of Hong Kong, Hong Kong SAR, China.; School of Biological Sciences, The University of Hong Kong, Hong Kong SAR, China.
Panagiotou G; School of Biological Sciences, The University of Hong Kong, Hong Kong SAR, China.; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; Department of Systems Biology and Bioinformatics, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), Jena, Germany.
Sim JPY; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Lie AKW; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Kwong YL; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2020 May; Vol. 9 (10), pp. 3371-3382. Date of Electronic Publication: 2020 Mar 18.
Typ publikacji:: Clinical Trial, Phase II; Journal Article
MeSH Terms:: Drug Resistance, Neoplasm*
Hematopoietic Stem Cell Transplantation*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Leukemia, Myeloid, Acute/*drug therapy
Adult ; Aged ; Chemotherapy-Induced Febrile Neutropenia/epidemiology ; Clofarabine/administration & dosage ; Cytarabine/administration & dosage ; Disease-Free Survival ; Female ; Humans ; Leukemia, Myeloid, Acute/genetics ; Male ; Middle Aged ; Mitoxantrone/administration & dosage ; Neoplasm Recurrence, Local ; Survival Rate ; Thrombocytopenia/chemically induced ; Thrombocytopenia/epidemiology ; Transplantation, Homologous ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Lau JSM"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język